Testing diabetes blood-sugar tracking for people with an LVAD
Part of Hormones & metabolism clinical trials.
This study looks at how well people with an LVAD can manage their blood sugar when they use a continuous glucose monitor app on a smartphone. It may help your diabetes care team adjust treatment using more complete sugar data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an LVAD pump placed using a modern design (HeartWare or HeartMate 3) sometime after 2010
- You have type 2 diabetes
- You are on diabetes treatment (any blood-sugar medicine or plan)
- Your LVAD has been in place for more than 3 months
- You can use a smartphone to upload glucose data using the LibreLink app
- You should be willing and able to return for a check-up at about 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a continuous glucose monitor (CGM) after leaving the hospital helps manage diabetes. You wear a small sensor on your arm that checks your sugar levels all day and sends them to your phone.
This study tests whether using a continuous glucose monitor (CGM) like the FreeStyle Libre 3 helps people with type 2 diabetes stay on their new GLP-1 or GIP/GLP-1 medication longer. You must be starting a GLP-1 or GIP/GLP-1 drug for the first time and not already using a CGM.
This study uses a continuous glucose monitor to help people with prediabetes or type 2 diabetes better manage their blood sugar and weight, and will test how well it works in a real-world workplace setting.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar in people with diabetes and gastroparesis (slow stomach emptying). If you have type 1 or type 2 diabetes and stomach symptoms, this could help doctors better understand your glucose patterns.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This trial tests whether using a continuous glucose monitor (CGM) helps people with both heart failure and diabetes manage their blood sugar better. It follows patients from hospital admission through discharge.
Hear when a new Hyperglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.